Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Rob Jones

EISAI

Eisai to make 200 cuts to US operations

Japanese firm says the restructure will help it stay competitive

- PMLiVE

AZ’s Onglyza may increase mortality, says FDA

Kombiglyze also under scrutiny

- PMLiVE

RSA name Kris Richards as senior consultant

Will aid the executive interims team

- PMLiVE

Pfizer launch grants programme for cardiovascular research

PCSK9 initiative is an extension of existing ASPIREprogramme

- PMLiVE

Pfizer and Merck flesh out Xalkori alliance details

First stage of building a combined oncology sales organisation

Shire Basingstoke

Silver lining as Shire rare disease programme hits a setback

Alagille syndrome candidate fails to meet phase II targets

- PMLiVE

IQWiG passes Boehringer lung cancer drug

Germany’s cost assessor says it can extend life in some patients, but benefit it ‘minor'

- PMLiVE

Pfizer and Pharmacy Voice launch NHS campaign

Campaign aims to reduce inappropriate use of A&E services 

- PMLiVE

Piramal sells clinical research arm to Indoco

Piramal Clinical Research sold for an undisclosed sum

- PMLiVE

Going the distance

Sanofi’s Pascale Witz on driving through change

- PMLiVE

FDA starts review of Novo’s refiled diabetes pair

Tresiba and Ryzodeg were rejected in 2013

- PMLiVE

Dr. Reddy’s enters €118m product agreement with UCB in India

Portfolio acquisition will expand firm’s therapy footprint

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links